Get to know our clinical trials
Clinical trial of the pharmacokinetics, safety and efficacy of ASTX727 in combination with venetoclax in AML
THE PURPOSE OF THE STUDY IS TO EVALUATE THE POTENTIAL INTERACTION BETWEEN ASTX727 AND VENETOCLAX, THE CLINICAL TRIAL DRUGS, TO EVALUATE SAFETY WHEN THE TRIAL DRUGS ARE TAKEN TOGETHER AND ANY POTENTIAL BENEFIT OF TAKING THE TRIAL DRUGS TOGETHER. THIS DRUG COMBINATION IS INVESTIGATIONAL, AS IT HAS NOT BEEN APPROVED TO TREAT AML.
Technical Summary
- SINGLE-ARM, OPEN-LABEL STUDY OF THE PHARMACOKINETICS, SAFETY, AND EFFICACY OF ASTX727 IN COMBINATION WITH VENETOCLAX IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA
- Code EudraCT: .
- Protocol number: ASTX727-07
- Promoter: Astex Pharmaceuticals, Inc.
- Link to Clinical Trials
* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.
More information about this clinical trial
Information offered by the Spanish Registry of Clinical Studies
- Summary
- Information
- Calendar
- Headquarters
- Drugs
Do you want to participate in this trial?
Request an appointment for our specialists to assess whether you qualify for this clinical trial
Do you prefer to send us your reports?
If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.